Table 1.
Study | Location | n | Transmission events |
% |
---|---|---|---|---|
Mothers who seroconverted during pregnancy | ||||
Tovo et al 22 | Italy | 10 | 2 | 20% |
Rudin et al 23 | Switzerland | 4 | 2 | 50% |
Hague et al 24 | UK | 9 | 5 | 56% |
Nielsen-Saines et al 25 | Brazil | 9 | 3 | 33% |
Roongpisuthipong et al 26 | Thailand | 15 | 2 | 13% |
Pooled | 47 | 14 | 30%† | |
Mothers who seroconverted during breastfeeding | ||||
Colebunders et al 27 | DRC | 3 | 1 | 33% |
Palasanthiran et al 28 | Australia | 11 | 3 | 27% |
Hira et al 29 | Zambia | 19 | 3 | 16% |
Van de Perre et al 30 | Rwanda | 15 | 8 | 53% |
Embree et al 31 | Kenya | 12 | 5 | 42% |
Liang et al 32 | China | 106 | 38 | 36% |
Humphrey et al 33 | Zimbabwe | 334 | -* | 24%* |
Pooled | 500 | 27%† |
A Kaplan-Meier approach was followed in calculating the cumulative proportion of children infected, and the number of children infected is therefore not shown.
All estimates were pooled using fixed effects models.